{"id":"W4303628848","doi":"10.1038/s42003-022-04011-6","title":"Multi-Omic analyses characterize the ceramide/sphingomyelin pathway as a therapeutic target in Alzheimer’s disease","year":2022,"lang":"en","type":"article","venue":"Communications Biology","topic":"Sphingolipid Metabolism and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":104,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta","funders":"National Institute on Aging; National Institute of Biomedical Imaging and Bioengineering; Canadian Institutes of Health Research; Qatar National Research Fund; Genentech; U.S. National Library of Medicine; IXICO; H. Lundbeck A/S; Servier; Eisai; Northern California Institute for Research and Education; Foundation for the National Institutes of Health; Fonds National de la Recherche Luxembourg; Pfizer; Biogen; BioClinica; F. Hoffmann-La Roche; University of Southern California; Novartis Pharmaceuticals Corporation; U.S. Department of Defense; Eli Lilly and Company; Bristol-Myers Squibb; Alzheimer's Disease Neuroimaging Initiative; Meso Scale Diagnostics; Alzheimer's Association; National Institutes of Health; U.S. Department of Health and Human Services","keywords":"Ceramide; Sphingomyelin; Disease; Computational biology; Alzheimer's disease; Biology; Bioinformatics; Medicine; Biochemistry; Pathology; Cholesterol","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009929915,0.0009092383,0.001310733,0.002309229,0.0004299577,0.001525326,0.0003104779,0.0004313606,0.001071815],"category_scores_gemma":[0.0007542842,0.0002012445,0.001321937,0.00229256,0.0002876538,0.0007740957,0.0008626386,0.0006609475,0.0002853302],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008962336,"about_ca_system_score_gemma":0.0008738384,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001692842,"about_ca_topic_score_gemma":0.002430239,"domain_scores_codex":[0.9996705,0.00007301493,0.00002796844,0.00008649602,0.00009987897,0.00004210011],"domain_scores_gemma":[0.9996496,0.0000961172,0.0001004372,0.00005512034,0.00006301242,0.00003557866],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00178734,0.0002433005,0.0688525,0.002085573,0.002154521,0.0007990415,0.0002929066,0.02069937,0.7333044,0.006344074,0.003058316,0.1603786],"study_design_scores_gemma":[0.0001596849,0.001091366,0.5065538,0.0006303765,0.004398075,0.001764072,0.001217665,0.1231506,0.2257717,0.0749657,0.06006476,0.0002321941],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8400774,0.03129359,0.08942137,0.003297948,0.0002025771,0.0002631886,0.02716846,0.0009232318,0.007352119],"genre_scores_gemma":[0.8993139,0.0166497,0.06539509,0.0009962968,0.0001480984,0.0002433472,0.01525946,0.0001672002,0.00182692],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002309229,"threshold_uncertainty_score":0.006502628,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1048340056253713,"score_gpt":0.3661946906333956,"score_spread":0.2613606850080242,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}